Evidence map›Paper›PMID 25832469›Full record

ReviewAdvances in therapy2015

A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care.

Lori E Crosby, Charles T Quinn, Karen A Kalinyak

Abstract readReview
In one paragraph

Review in Advances in therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Design and Refinement of CyberCellJournal of medical extended reality · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lori E CrosbyCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, lori.crosby@cchmc.org.
Charles T Quinn
Karen A Kalinyak

Funding

Cincinnati Center of Excellence in Hemoglobinopathies ResearchU01HL117709 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MALIK, PUNAM · 2013 to 2017
$8.9M
Patient-Provider Interventions to Improve Transition to Adult Care in SCDK07HL108720 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CROSBY, LORI E · 2011 to 2014
$1.6M
NHLBI NIH HHS K07 HL108720NHLBI NIH HHS K07HL108720NHLBI NIH HHS U01 HL117709NHLBI NIH HHS U01HL117709
6 · The paper itself

Abstract

The lifespan of patients with sickle-cell disease (SCD) continues to increase, and most affected individuals in high-resource countries now live into adulthood. This necessitates a successful transition from pediatric to adult health care. Care for transitioning patients with SCD often falls to primary care providers who may not be fully aware of the many challenges and issues faced by patients and the current management strategies for SCD. In this review, we aim to close the knowledge gap between primary care providers and specialists who treat transitioning patients with SCD. We describe the challenges and issues encountered by these patients, and we propose a biopsychosocial multidisciplinary approach to the management of the identified issues. Examples of this approach, such as transition-focused integrated care models and quality improvement collaboratives, with the potential to improve health outcomes in adulthood are also described.

Indexed as

Disease ManagementAdultAge FactorsAnemia, Sickle CellChildHumansInsurance CoverageInsurance, HealthInterpersonal RelationsLife ExpectancyMedication AdherencePain ManagementPatient Care TeamPrimary Health CareSocial WorkTransition to Adult Care

Identifiers

PMID25832469
PMCPMC4415939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.